BRPI0912542A2 - derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas. - Google Patents
derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas.Info
- Publication number
- BRPI0912542A2 BRPI0912542A2 BRPI0912542A BRPI0912542A BRPI0912542A2 BR PI0912542 A2 BRPI0912542 A2 BR PI0912542A2 BR PI0912542 A BRPI0912542 A BR PI0912542A BR PI0912542 A BRPI0912542 A BR PI0912542A BR PI0912542 A2 BRPI0912542 A2 BR PI0912542A2
- Authority
- BR
- Brazil
- Prior art keywords
- airways
- pyrazine
- diamino
- chloro
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
- C07D241/28—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08156060 | 2008-05-13 | ||
PCT/EP2009/055657 WO2009138378A1 (en) | 2008-05-13 | 2009-05-11 | 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912542A2 true BRPI0912542A2 (pt) | 2015-10-13 |
Family
ID=39627401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912542A BRPI0912542A2 (pt) | 2008-05-13 | 2009-05-11 | derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas. |
Country Status (12)
Country | Link |
---|---|
US (1) | US8664228B2 (pt) |
EP (1) | EP2285785B1 (pt) |
JP (1) | JP2011520831A (pt) |
KR (1) | KR20110011621A (pt) |
CN (1) | CN102015662A (pt) |
AU (1) | AU2009248179A1 (pt) |
BR (1) | BRPI0912542A2 (pt) |
CA (1) | CA2723938A1 (pt) |
EA (1) | EA201001772A1 (pt) |
ES (1) | ES2394241T3 (pt) |
MX (1) | MX2010012441A (pt) |
WO (1) | WO2009138378A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
CN101951913A (zh) | 2008-02-26 | 2011-01-19 | 帕里昂科学公司 | 聚芳族钠通道阻断剂 |
BRPI0915018A2 (pt) * | 2008-06-10 | 2015-10-27 | Novartis Ag | compostos orgânicos |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
US9050339B2 (en) | 2010-09-17 | 2015-06-09 | Novartis Ag | Pyrazine derivatives as ENaC blockers |
US8372845B2 (en) * | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
WO2013038386A1 (en) * | 2011-09-16 | 2013-03-21 | Novartis Ag | Heterocyclic compounds for the treatment of cystic fibrosis |
WO2013064451A1 (en) | 2011-11-02 | 2013-05-10 | Boehringer Ingelheim International Gmbh | Novel process for the preparation of acylguanidines and acylthioureas |
CA2854217C (en) * | 2011-11-02 | 2019-12-31 | Boehringer Ingelheim International Gmbh | Substituted pyrazinoylguanidine compounds and their use as epithelial sodium channel blockers, medicaments containing said compounds and processes for the preparation thereof |
US8859559B2 (en) * | 2011-12-20 | 2014-10-14 | Boehringer Ingelheim International Gmbh | Substituted pyrazines and their use in the treatment of disease |
WO2013174757A1 (en) | 2012-05-25 | 2013-11-28 | Boehringer Ingelheim International Gmbh | Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof |
WO2014044849A1 (en) * | 2012-09-24 | 2014-03-27 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
EP2925316A1 (en) * | 2012-11-28 | 2015-10-07 | Grünenthal GmbH | Substituted amino-arylcarboxamides as kcnq2/3 modulators |
HUE032891T2 (hu) | 2012-12-17 | 2017-11-28 | Parion Sciences Inc | Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére |
US9029382B2 (en) | 2012-12-17 | 2015-05-12 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds |
US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
UY36034A (es) | 2014-03-18 | 2015-09-30 | Astrazeneca Ab | Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos |
GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
WO2022189636A1 (en) * | 2021-03-12 | 2022-09-15 | Biomedcode Hellas Sa | Anti-inflammatory carboxamide derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3361244D1 (de) * | 1982-01-29 | 1986-01-02 | Ici Plc | Alkanolamine derivatives |
US4803206A (en) * | 1988-03-07 | 1989-02-07 | Schering Corporation | Antihypertensive acylpyrazines |
JP2007502827A (ja) * | 2003-08-18 | 2007-02-15 | パリオン・サイエンシィズ・インコーポレーテッド | 脂肪族ピラジノイルグアニジンナトリウムチャネルブロッカー |
KR20070059063A (ko) | 2004-08-18 | 2007-06-11 | 마이클 알 존슨. | 지방족 아미드 및 에스테르 피라지노일구아니딘 나트륨채널 차단제 |
-
2009
- 2009-05-11 KR KR1020107025425A patent/KR20110011621A/ko not_active Application Discontinuation
- 2009-05-11 CN CN2009801161135A patent/CN102015662A/zh active Pending
- 2009-05-11 JP JP2011508884A patent/JP2011520831A/ja active Pending
- 2009-05-11 AU AU2009248179A patent/AU2009248179A1/en not_active Abandoned
- 2009-05-11 EA EA201001772A patent/EA201001772A1/ru unknown
- 2009-05-11 WO PCT/EP2009/055657 patent/WO2009138378A1/en active Application Filing
- 2009-05-11 US US12/990,905 patent/US8664228B2/en not_active Expired - Fee Related
- 2009-05-11 ES ES09745710T patent/ES2394241T3/es active Active
- 2009-05-11 MX MX2010012441A patent/MX2010012441A/es not_active Application Discontinuation
- 2009-05-11 CA CA2723938A patent/CA2723938A1/en not_active Abandoned
- 2009-05-11 EP EP09745710A patent/EP2285785B1/en not_active Not-in-force
- 2009-05-11 BR BRPI0912542A patent/BRPI0912542A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2010012441A (es) | 2010-12-06 |
CN102015662A (zh) | 2011-04-13 |
KR20110011621A (ko) | 2011-02-08 |
EP2285785B1 (en) | 2012-09-05 |
EP2285785A1 (en) | 2011-02-23 |
US20110059989A1 (en) | 2011-03-10 |
US8664228B2 (en) | 2014-03-04 |
AU2009248179A1 (en) | 2009-11-19 |
EA201001772A1 (ru) | 2011-06-30 |
CA2723938A1 (en) | 2009-11-19 |
WO2009138378A1 (en) | 2009-11-19 |
JP2011520831A (ja) | 2011-07-21 |
ES2394241T3 (es) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0912542A2 (pt) | derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas. | |
BRPI0810411A2 (pt) | Derivados de sulfonil amida para o tratamento de crescimento celular anormal | |
BRPI0924427A2 (pt) | composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma | |
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BRPI0912356A2 (pt) | compostos moduladores de sirtuína, composição farmacêutica compreendendo os mesmos e seu uso | |
BRPI0816116A2 (pt) | Derivados de indol 2,3-substituídos para o tratamento de infecções virais. | |
DK2300443T3 (da) | Triazolderivater, der er anvendelige til behandling af sygdomme | |
BRPI1009481A2 (pt) | compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos | |
BRPI1009981A2 (pt) | sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula | |
BRPI0813352A2 (pt) | Composições de fragmento de tecido para o tratamento de incontinência | |
BRPI0911577A8 (pt) | derivados espiro-indol para o tratamento de doenças parasíticas. | |
ECSP12011946A (es) | Derivados de dioxa- biciclo [3.2.1] octano- 2 ,3,4- triol | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
CR10508A (es) | Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica | |
CL2007003671A1 (es) | Metodo para la preparacion de derivados del acido 2-amino-5-cianobenzoico, utiles como intermediarios para la preparacion de las correspondientes diamidas cianoantranilicas. | |
BR112012003372A2 (pt) | vitamina d3 e análogos da mesma para o tratamento de alopecia. | |
BRPI0920862A2 (pt) | composição, método para fabricação da mesma, e uso da mesma | |
BRPI0914410A2 (pt) | composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares. | |
BRPI1016257A2 (pt) | composições compreendendo finafloxacino e métodos para tratar infecções oftálmicas, ópticas ou nasais | |
BRPI1008727A2 (pt) | derivados de azol substituídos, composição farmacêutica contendo os derivados, e método para o tratamento de doença de parkinson usando os mesmos | |
BRPI0822012A2 (pt) | Derivados de quinazolina de 6,7-dialcóxi úteis para o tratamento de distúrbios relacionados com câncer | |
BR112013012072A2 (pt) | derivados, composições de benzodiazepina e métodos para o tratamento de danos cognitivos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |